Interleukin-1 and transforming growth factor-β 1 as crucial factors in osteoarthritic cartilage metabolism

Connective Tissue Research

Volumn 49, Issue 3-4, 2008, Pages 293-297

  Pujol, Jean Pierre ^a   Chadjichristos, Christos ^a   Legendre, Florence ^a   Bauge, Catherine ^a   Beauchef, Gallic ^a   Andriamanalijaona, Rina ^a   Galera, Philippe ^a   Boumediene, Karim ^a  

^a UNIVERSITÉ DE CAEN   (France)

Author keywords

Cartilage; Interleukin 1; Osteoarthritis; Transforming growth factor ss type II receptor; Type II collagen

Indexed keywords

COLLAGEN TYPE 2; INTERLEUKIN 1; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ARTICULAR CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROGENESIS; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; INTRON; METABOLISM; MOLECULAR MECHANICS; OSTEOARTHRITIS; PATHOGENESIS; PATHOPHYSIOLOGY; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RECEPTOR INTRINSIC ACTIVITY; REVIEW;

ANIMALS; CARTILAGE, ARTICULAR; CHONDROCYTES; COLLAGEN TYPE II; HUMANS; INTERLEUKIN-1; OSTEOARTHRITIS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

EID: 48549086489     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.1080/03008200802148355     Document Type: Review

References (54)

1. Kuettner, K. E. and Cole, A. A. (2005) Cartilage degeneration in different human joints. 13, pp. 93-103.
2. Felson, D. T., Gale, D. R., Elon, G. M., Niu, J., Hunter, D. J., Goggins, J. and Lavalley, M. P. (2005) Osteophytes and progression of knee osteoarthritis. 44, pp. 100-104.
3. Brighton, C. T. and Heppenstall, R. B. (1971) Oxygen tension in zones of the epiphyseal plate, the metaphysis and diaphysis: An in vitro and in vivo study in rats and rabbits. 53, pp. 719-728.
4. Rajpurohit, R., Koch, C. J., Tao, Z., Teixerira, C. M. and Shapiro, I. M. (1996) Adaptation of chondrocytes to low oxygen tension: Relationship between hypoxia and cellular metabolism. 168, pp. 424-432.
5. Pritzker, K. P., Gay, S., Jimenez, S. A., Ostergaard, K., Pelletier, J. P., Revell, P. A., Salter, D. and Van Den Berg, W.B. (2006) Osteoarthritis cartilage histopathology: Grading and staging. 14, pp. 13-29.
6. Dingle, J. T. (1981) Catabolin-a cartilage catabolic factor from synovium. 156, pp. 219-231.
7. Pujol, J. P. and Loyau, G. (1987) Interleukin-1 and osteoarthritis. 41, pp. 1187-1198.
8. Wood, D. D., Ihrie, E. J., Dinarello, C. A. and Cohen, P. L. (1983) Isolation of an interleukin-1 like factor from human joint effusions. 26, pp. 975-983.
9. Pelletier, J. P. and Martel-Pelletier, J. (1989) Evidence for the involvement of interleukin-1 in human osteoarthritic cartilage degradation: Protective effect of NSAID. 16, pp. 19-27.
10. Farahat, M. N., Yanni, G., Poston, R. and Panayi, G. S. (1993) Cytokine expression in synovial membranes of patients with rheumatoid arthritis and ostoarthritis. 52, pp. 870-875.
11. Martel-Pelletier, J., Zafarullah, M., Kodama, S. and Pelletier, J. P. (1991) In vitro effects of interleukin-1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage. 18, pp. 80-84.
12. Martel-Pelletier, J. (2004) Pathophysiology of osteoarthritis. 12, pp. S31-S33.
13. Pasternak, R. D., Hubbs, S. J., Caccese, RG, Marks, R. L., Conaty, J. M. and DiPasquale, G. (1986) Interleukin-1 stimulates the secretion of proteoglycan- and collagen-degrading proteases by rabbit articular chondrocytes. 41, pp. 351-367.
14. Bocquet, J., Daireaux, M., Langris, M., Jouis, V., Pujol, J. P., Beliard, R. and Loyau, G. (1986) Effect of a interleukin-1 like factor (mononuclear cell factor) on proteoglycan synthesis in cultured human articular chondrocytes. 134, pp. 539-549.
15. Goldring, M. B., Birkead, J., Kimura, T. and Krane, S. M. (1988) Interleukin-1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. 82, pp. 2026-2037.
16. Lefebvre, V., Peeters-Joris, C. and Vaes, G. (1990) Modulation by interleukin-1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. 366, pp. 1052-1378.
17. Pelletier, J. P., Martel-Pelletier and Howell, D. S. (1997) Etiopathogenesis of osteoarthritis. pp. 1969-1984. (Williams & Wilkins), Baltimore
18. Guerne, P. A., Zuraw, B. L., Vaughan, J. H., Carson, D. A. and Lotz, M. (1989) Synovium as a source of interleukin-6 in vitro. Contribution to local and systemic manifestations of arthritis. 83, pp. 585-592.
19. Legendre, F., Dudhia, J., Pujol, J. P. and Bogdanowicz, P. (2003) JAK/ STAT but not ERK1/ERK2 pathway mediates IL-6/sIL-6R down-regulation of type II collagen, aggrecan core and link protein transcription in articular chondrocytes. 278, pp. 2903-2912.
20. Legendre, F., Pujol, J. P., Boumediene, K. and Bogdanowicz, P. (2005) Role of IL-6/IL-6R induced STATs and MAPK/ERKs in up-regulation of MMPs (-1, -3, -13) and ADAMTS (-4, -5/11) gene expression in articular chondrocytes. 32, pp. 1307-1316.
21. Van Den Berg, W.B., van der Kraan, P. M. and van Beuningen, H. M. (1999) Role of growth factors and cartilage repair. pp. 188-209. Springer-Verlag, Berlin Heidelberg, New York
22. Galera, P., Redini, F., Vivien, D., Bonaventure, J., Penfornis, H., Loyau, G. and Pujol, J. P. (1992) Effect of transforming growth factor-ss1 (TGF-β1) on matrix synthesis by monolayer cultures of rabbit articular chondrocytes during the dedifferentiation process. 200, pp. 379-392.
23. Redini, F., Galera, P., Mauviel, A., Loyau, G. and Pujol, J. P. (1988) Transforming growth factor-ss stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytes. 234, pp. 172-176.
24. Redini, F., Daireaux, M., Mauviel, A., Galera, P., Loyau, G. and Pujol, J. P. (1991) Characterization of proteoglycans synthesized by rabbit articular chondrocytes in response to transforming growth factor-ss. 196, pp. 1093-1206.
25. Redini, F., Mauviel, A., Pronost, S., Loyau, G. and Pujol, J. P. (1993) Transforming growth factor ss exerts opposite effects from Interleukin-1ss (IL-1ss) on cultured rabbit articular chondrocytes through reduction of IL-1 receptor expression. 36, pp. 44-50.
26. Van Der Kraan, P. M., Glansbeek, H. L., Vitters, E. L. and van den Berg, W.B. (1997) Early elevation of transforming growth factor-ss, decorin and biglycan mRNA levels during cartilage matrix restoration after mild proteoglycan depletion. 24, pp. 543-549.
27. Boumediene, K., Conrozier, T., Mathieu, P., Richard, M., Marcelli, C., Vignon, E. and Pujol, J. P. (1998) Decrease of cartilage transforming growth factor-ss receptor II expression in the rabbit experimental osteoarthritis-potential role in cartilage breakdown. 6, pp. 146-149.
28. Zhou, G., Lefebvre, V., Zhang, Z. P., Eberspaecher, H. and de Crombrugghe, B. (1998) Three high mobility group-like sequences within a 48-base pair enhancer of the COL2A1 gene are required for cartilage-specific expression in vivo. 273, pp. 14989-14997.
29. Lefebvre, V., Li, P. and de Crombrugghe, B. (1998) A new long form of SOX5 (L-SOX5), SOX6 and SOX9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. 17, pp. 5718-5733.
30. Ghayor, C., Herrouin, J. -F., Chadjichristos, C., Ala-Kokko, L., Takigawa, M., Pujol, J. P. and Galera, P. (2000) Regulation of human COL2A1 gene expression in chondrocytes. Identification of C-Krox responsive elements and modulation by phenotype alteration. 275, pp. 27421-27438.
31. Ghayor, C., Chadjichristos, C., Herrouin, J. -F., Ala-Kokko, L., Suske, G., Pujol, J. P. and Galera, P. (2001) Sp3 represses the Sp1-mediated transactivation of human COL2A1 gene in primary and dedifferentiated chondrocytes. 276, pp. 36881-36895.
32. Chadjichristos, C., Ghayor, C., Herrouin, J. -F., Ala-Kokko, L., Suske, G., Pujol, J. P. and Galera, P. (2002) Sp3 represses the Sp1-mediated transactivation of the human COL2A1 gene in primary and de-differentiated chondrocytes. 276, pp. 36881-36895.
33. Goldring, M. B., Suen, L. -F., Yamin, R. and Lai, W. F. (1996) Regulation of collagen gene expression by prostaglandins and interleukin-1beta in cultured chondrocytes and fibroblast. 3, pp. 9-16.
34. Goldring, M. B., Birkhead, J. R., Suen, L. F., Yamin, R., Mizuno, S., Glowaski, J., Arbiser, J. L. and Appeley, J. F. (1994) Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. 94, pp. 2307-2316.
35. Murakami, S., Lefebvre, V. and de Crombrugghe, B. (2000) Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha. 275, pp. 3687-3692.
36. Tan, L., Peng, H., Osaki, M., Choy, B. K., Auron, P. E., Sandell, L. J. and Goldring, M. B. (2003) Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1beta. 278, pp. 17688-17700.
37. Chadjichristos, C., Ghayor, C., Kypriotou, M., Martin, G., Renard, E., Ala-Kokko, L., Suske, G., De Crombrugghe, B., Pujol, J. -P. and Galera, P. (2003) Sp1 and Sp3 transcription factors mediate IL-1ss down-regulation of human type II collagen gene expression in articular chondrocytes. 278, pp. 39762-39772.
38. Serra, R., Johnson, M., Filvaroff, E. H., Laborde, J., Sheehan, D. M., Derynck, R. and Moses, H. L. (1997) Expression of a truncated kinase defective TGF-β type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. 139, pp. 541-552.
39. van Beuningen, H. M., van der Kraan, P. M., Arntz, O. J. and van den Berg, W.B. (1994) In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-ss 1: Age-related differences. 53, pp. 593-600.
40. Andriamanalijaona, R., Felisaz, N., Kim, S. J., King-Jones, K., Lehmann, M., Pujol, J. P. and Boumediene, K. (2003) Mediation of interleukin-1ss-induced transforming growth factor-ss1 expression by activator protein 4 transcription factor in primary cultures of bovine articular chondrocytes: Possible cooperation with activator protein 1. 48, pp. 1570-1581.
41. Bauge, C., Legendre, F., Leclercq, S., Elissalde, J. M., Pujol, J. P., Galera, P. and Boumediene, K. (2007) Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes. 56, pp. 3020-3032.
42. Bae, H. W., Geiser, A. G., Kim, D. H. Chung, M. T. et al. (1995) Characterization of the promoter region of the human transforming growth factor-ss type II receptor gene. 270, pp. 29460-29468.
43. Choi, S. G., Yi, Y. S., Kim, Y. S., Kato, J., Chang, J., Chung, H. W., Hahm, K. B., Yang, H. K., Rhee, H. H., Bang, Y. J. and Kim, S. J. (1998) A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-ss type II receptor. 273, pp. 110-117.
44. Kelly, D., Kim, S. J. and Rizzino, A. (1998) Transcripttional activation of the type II transforming growth factor-ss receptor gene upon differentiation of embryonal carcinoma cells. 273, pp. 21115-21124.
45. Kopp, J. L., Wilder, P. J., Desler, M., Kim, J. H., Hou, J., Nowling, T. and Rizzino, A. (2004) Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1 on the promoter of the type II transforming growth factor-ss receptor gene. 279, pp. 19407-19420.
46. Lee Park, S.H. S.R., Kim, B. C., Cho, E. A., Patel, S. P., Kang, H. B., Sausville, E. A., Nakanishi, O., Trepel, J. B., Lee, B. I. and Kim, S. J. (2002) Transcriptional regulation of the transforming growth factor-ss type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells. 277, pp. 5168-5174.
47. Lee, B. I., Park, S. H., Kim, J. W., Sausville, E. A. Kim, H. T. et al. (2001) MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor-ss type II receptor expression in human breast cancer cells. 61, pp. 931-934.
48. Park, S. H., Kim, Y. S., Park, B. K., Hougaard, S. and Kim, S. J. (2001) Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen henein human gastric cancer cell lines: Implication for the loss of TGF-β type II receptor expression. 20, pp. 1235-1245.
49. Bauge, C., Attia, J., Leclercq, S., Pujol, J. P., Galera, P. and Boumediene, K. (2008) IL-1ss upregulates Smad7 via NF-kB activation in human chondrocytes. 58, pp. 221-226.
50. Bauge, C., Beauchef, G., Leclercq, S., Kim, S. J., Pujol, J. P. and Galera, P. (2008) NF-kB mediates IL-1B-induced down-regulation of T. ssRII through the modulation of Sp3 expression.
51. Monslow, J., Williams, J. D., Fraser, D. J., Michael, D. R., Foka, P., Kift-Morgan, A. P., Luo, D. D., Fielding, C. A., Craig, K. J., Topley, N., Jones, S. A., Ramji, D. P. and Bowen, T. (2006) Sp1 and Sp3 mediate constitutive transcription of the human hyaluronan synthase 2 gene. 281, pp. 18043-18050.
52. Hahm, K. B., Cho, K., Lee, C., Im, Y. H., Chang, J., Choi, S. G., Sorensen, P. H., Thiele, C. J. and Kim, S. J. (1999) Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein. 23, pp. 222-227.
53. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W. Vogelstein, B. et al. (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. 268, pp. 1336-1338.
54. Park, K., Kim, S. J., Bang, Y. J., Park, J. G., Kim, N. K., Roberts, A. B. and Sporn, M. B. (1994) Genetic changes in the transforming growth factor-ss (TGF-β) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β. 91, pp. 8772-8776.